DGX DMA
As of date:12/1/2022
DGX stock price:152.61
DGX 50 DMA:137.42
DGX 200 DMA:134.78
DGX MACD (200-50):-2.64

Also see:
DGX Market Cap History
DGX Shares Outstanding History
DGX YTD Return
DGX RSI
DGX MACD
DGX Technical Analysis

DraftKings Breaks Above 200-Day Moving Average - Bullish for DKNG
1 hour, 8 minutes ago


NGMS Crosses Above Key Moving Average Level
1 hour, 8 minutes ago


DT Makes Bullish Cross Above Critical Moving Average
1 hour, 13 minutes ago


Repligen (RGEN) Shares Cross Above 200 DMA
1 hour, 14 minutes ago


CVCO Crosses Above Key Moving Average Level
1 hour, 15 minutes ago


Alexander & Baldwin Breaks Above 200-Day Moving Average - Bullish for ALEX
1 hour, 16 minutes ago


KGC Crosses Above Key Moving Average Level
1 hour, 23 minutes ago


SR Crosses Below Key Moving Average Level
1 hour, 23 minutes ago


Bullish Two Hundred Day Moving Average Cross - PCY
1 hour, 23 minutes ago


Minerals Technologies Breaks Above 200-Day Moving Average - Bullish for MTX
1 hour, 23 minutes ago


iShares iBonds Dec 2022 Term Corporate Breaks Below 200-Day Moving Average - Notable for IBDN
1 hour, 23 minutes ago


Suncor Energy (SU.CA) Shares Cross Below 200 DMA
1 hour, 23 minutes ago


FROG Crosses Above Key Moving Average Level
3 hours, 38 minutes ago


Freshworks Breaks Above 200-Day Moving Average - Bullish for FRSH
3 hours, 42 minutes ago


VRSK Makes Bullish Cross Above Critical Moving Average
4 hours, 18 minutes ago


More Technical Analysis News

DGX DMADGX MACD
Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.

When researching a stock like Quest Diagnostics, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from DGX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for DGX stock — the real life supply and demand for the stock over time — and examines that data in different ways. One of those ways is to calculate a Simpe Moving Average ("SMA") by looking back a certain number of days. One of the most popular "longer look-backs" is the DGX 200 day moving average ("DGX 200 DMA"), while one of the most popular "shorter look-backs" is the DGX 50 day moving average ("DGX 50 DMA"). A chart showing both of these popular moving averages is shown on this page for Quest Diagnostics.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Quotes delayed 20 minutes

Email EnvelopeFree DGX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Quest Diagnostics (DGX) is categorized under the Healthcare sector; to help you further research DMA, below are some other companies in the same sector:

DHR DMA
DVA DMA
DXCM DMA
ELV DMA
EW DMA
GILD DMA
HCA DMA
HOLX DMA
HSIC DMA
IDXX DMA
More Healthcare companies »

 

DGX DMA | www.StockDMA.com | Copyright © 2019 - 2022, All Rights Reserved

Nothing in StockDMA.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.